Skip to main content
. 2019 May 23;2019(5):CD008388. doi: 10.1002/14651858.CD008388.pub3

Comparison 2. Compensative interventions versus control, placebo or no intervention.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Visual field 2 95 Std. Mean Difference (IV, Random, 95% CI) ‐0.11 [‐0.92, 0.70]
2.1.1 Participants with visual field defects (no visual neglect) 2 95 Std. Mean Difference (IV, Random, 95% CI) ‐0.11 [‐0.92, 0.70]
2.1.2 Participants with visual field defects and (possibly) co‐existing visual neglect 0 0 Std. Mean Difference (IV, Random, 95% CI) Not estimable
2.2 Extended activities of daily living 2 87 Std. Mean Difference (IV, Random, 95% CI) 0.49 [‐0.01, 0.99]
2.2.1 Participants with visual field defects (no visual neglect) 2 87 Std. Mean Difference (IV, Random, 95% CI) 0.49 [‐0.01, 0.99]
2.2.2 Participants with visual field defects and (possibly) co‐existing visual neglect 0 0 Std. Mean Difference (IV, Random, 95% CI) Not estimable
2.3 Reading 4 162 Std. Mean Difference (IV, Random, 95% CI) 0.26 [‐0.05, 0.58]
2.3.1 Participants with visual field defects (no visual neglect) 3 110 Std. Mean Difference (IV, Random, 95% CI) 0.18 [‐0.20, 0.56]
2.3.2 Participants with visual field defects and (possibly) co‐existing visual neglect 1 52 Std. Mean Difference (IV, Random, 95% CI) 0.45 [‐0.10, 1.00]
2.4 Quality of life 2 96 Mean Difference (IV, Random, 95% CI) 9.36 [3.10, 15.62]
2.4.1 Participants with visual field defects (no visual neglect) 2 96 Mean Difference (IV, Random, 95% CI) 9.36 [3.10, 15.62]
2.4.2 Participants with visual field defects and (possibly) co‐existing visual neglect 0 0 Mean Difference (IV, Random, 95% CI) Not estimable
2.5 Scanning ‐ cancellation 2 97 Std. Mean Difference (IV, Random, 95% CI) ‐0.01 [‐0.40, 0.39]
2.5.1 Participants with visual field defects (no visual neglect) 1 48 Std. Mean Difference (IV, Random, 95% CI) 0.12 [‐0.45, 0.68]
2.5.2 Participants with visual field defects and (possibly) visual neglect 1 49 Std. Mean Difference (IV, Random, 95% CI) ‐0.13 [‐0.69, 0.44]
2.6 Adverse events 2 108 Odds Ratio (M‐H, Random, 95% CI) 5.18 [0.24, 112.57]